Drug Manufacturers’ Supply Options Could Be Constricted By Legislation
This article was originally published in The Tan Sheet
Executive Summary
Congressional efforts to legislate greater emphasis on drug quality, both by FDA and the industry, could render a more compact supply chain for manufacturers